Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact.

ABSTRACT:

Background

In 2020, an international expert panel proposed a new definition of fatty liver: Metabolic dysfunction-associated fatty liver disease (MAFLD). The MAFLD added the criteria for defining metabolic dysfunctions, which are high-risk factors for liver-related and cardiovascular events. Contrary to the non-alcoholic fatty liver disease (NAFLD) definition, it allows the coexistence of MAFLD and significant alcohol use in the same patient.

Aim

To review the existing data that evaluate the clinical profile and long-term outcome difference between the patients identified as MAFLD and NAFLD.

Methods

Databases MEDLINE via PubMed and EMBASE were searched and relevant publications up to June 28, 2022 were assessed. Studies were included if they involved human part

SUBMITTER: Tang SY 

PROVIDER: S-EPMC9850940 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature